Monte Rosa Therapeutics
GLUE
#6712
Rank
A$1.11 B
Marketcap
A$13.05
Share price
-3.03%
Change (1 day)
-40.72%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2026 (TTM): A-$2.50

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.58. In 2025 the company made an earnings per share (EPS) of A-$1.17 an increase over its 2024 EPS that were of A-$1.56.

EPS history for Monte Rosa Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.50114.38%
2025A-$1.17-25.22%
2024A-$1.56-60.93%
2023A-$3.9915.28%
2022A-$3.46